T1	Participants 70 113	pulmonary arterial hypertension in children
T2	Participants 543 562	29 children treated
T3	Participants 864 905	All were receiving background PAH therapy
T4	Participants 1666 1709	background targeted PAH therapy in children
T5	Participants 1834 1861	pediatric patients with PAH
